In Treatment of Anemia due to chronic kidney disease Anemia is a condition where your body does not have enough red blood cells to carry oxygen around your body. Chronic kidney disease (CKD) refers to the loss of normal kidney function over a long span of time. CKD progresses gradually over a few years but may become permanent if left untreated. CKD can lead to anemia. Cresp Onco 200mcg Injection can boost your levels of red blood cells and reduce the symptoms of anemia such as tiredness and weakness. Taking this injection improves the quality of life. In Treatment of Anemia due to cancer chemotherapy Low red blood cell count is termed as anemia. Cancer treatment with chemotherapy often causes many side effects, one of the major ones being anemia. Cresp Onco 200mcg Injection stimulates the production of red blood cells in bone marrow and regulates the haemoglobin in the blood. This treats anemia in cancer patients receiving chemotherapy.
It is not known whether it is safe to consume alcohol with Cresp Onco 200mcg Injection. Please consult your doctor.
Cresp Onco 200mcg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Cresp Onco 200mcg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Cresp Onco 200mcg Injection does not usually affect your ability to drive.
Cresp Onco 200mcg Injection is safe to use in patients with kidney disease. No dose adjustment of Cresp Onco 200mcg Injection is recommended.
Cresp Onco 200mcg Injection should be used with caution in patients with liver disease. Dose adjustment of Cresp Onco 200mcg Injection may be needed. Please consult your doctor.
If you miss a dose of Cresp Onco 200mcg Injection, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Cipla Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zydus Cadila || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Hetero Drugs Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Hetero Drugs Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Indiabulls pharmaceutical ltd || ₹14.5/tablet (25% cheaper)